Sorrento therapeutics

Beleggen in aandelen beurs New York, Dow Jones, Nasdaq-100 en S&P500

Beleggen met ongekend lage tarieven?
Aandelen BE/NL €2+0,03% / VS €0,50+$0,004 p/st
Kernselectie: Geen kosten turbo's, ETF's en fondsen
DEGIRO: meer informatie / rekening openen


believer
Forum elite
Forum elite
Berichten: 5095
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4413
Contacteer:

Re: Sorrento therapeutics

Bericht door believer »

ancaoli liked last!







Volg Beursig.com op Twitter en Facebook


ancaoli
Forum veteraan
Forum veteraan
Berichten: 1877
Lid geworden op: 28 jan 2018 18:54
waarderingen: 994
Contacteer:

Re: Sorrento therapeutics

Bericht door ancaoli »

Tegelijkertijd ook annulering van 1499 clinical trial wegens moeilijke recrutering patiënten; toch wel vreemd in volle pandemie. Nu wat mij betreft geen probleem zolang ze wel verder doen met de 2020 versie...


https://clinicaltrials.gov/ct2/show/NCT ... vid&draw=2
Vaste Portefeuille:Recticel, WRN, Accentis, Global G, Roularta, Argenx, Agfa, Ontex, OCI, Sorrento, Inventiva

alwaysright
Forum actieveling
Forum actieveling
Berichten: 956
Lid geworden op: 10 mei 2013 19:25
waarderingen: 397
Contacteer:

Re: Sorrento therapeutics

Bericht door alwaysright »

Ze zijn bij Sorrento toch zeker nog iets van plan....


Lead Information Systems/Mobile APP Project Coordinator
· San Diego, California
ABOUT US



Sorrento Therapeutics Inc. is a fast growing, clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases. Sorrento's multimodal multipronged approach to fighting cancer is made possible by its' extensive immuno-oncology platforms, including key assets such as fully human antibodies ("G-MAB™ library"), clinical stage immuno-cellular therapies ("CAR-T"), intracellular targeting antibodies ("iTAbs"), antibody-drug conjugates ("ADC"), and clinical stage oncolytic virus ("Sephrevir®").



We attract smart people who play well with others. We're small enough for your ideas to make a big impact, and large enough to offer you opportunities to grow professionally at any stage of your career.



If you’re a quick learner, enjoy working in the biotech industry, and share our mission of providing ground-breaking impact to medicine, each other, and our patients, Sorrento Therapeutics is the place for you!



WHAT WE ARE LOOKING FOR:



Sorrento Therapeutics (“Sorrento”) is seeking an experienced Lead Information Systems/Mobile APP Project Coordinator. The Lead Project Coordinator’s focus will be to help oversee the operations of the COVI-STIX mobile application as well as other clinical laboratory information systems projects. Work as a liaison with technology partner, internal stakeholders and any other related departments. The Lead Project Coordinator is responsible for executing and evaluation of projects according to predetermined requirements, timelines and budgets, managing project teams and maintaining quality control throughout project life cycles.



WHAT YOU’LL DO:



Be the point of contact for all stakeholders, management, technology partner.
Responsible for gathering requirements and providing the necessary information.
Responsible for assessing and advising on requirements, status, issues, etc.
Work as liaison in responding to the needs and requests on a timely basis for the project.
Schedule and attend meetings, on an ongoing basis, to review progress.
Provide project schedule to identify when each task will be performed and update all parties regularly.
Clearly communicate expectations to team members
Effectively manage projects by ensuring any changes are documented and approved.




EDUCATION AND QUALIFICATIONS:



Technical and educational background in IT/computer science/programming with a bachelor’s degree at a minimum
App management/development background
Good communication and listening skills.


YOUR REWARD:



Support scientists who are on the leading edge of immunotherapies for the treatment of cancer.
Earn a competitive salary that allows you to focus your attention on your passion.
A comprehensive benefits package including: medical, dental, vision, life and disability insurance, matching 401k, company paid holidays, and Flexible PTO, plus stock options.


If this sounds like the right career to fit your personality and interests, please apply, we’re looking forward to meeting you!



Principals only. Recruiters, please don't contact this job poster.



Sorrento Therapeutics, Inc. is an Equal Opportunity Employer
believer liked last!

believer
Forum elite
Forum elite
Berichten: 5095
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4413
Contacteer:

Re: Sorrento therapeutics

Bericht door believer »


believer
Forum elite
Forum elite
Berichten: 5095
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4413
Contacteer:

Re: Sorrento therapeutics

Bericht door believer »


believer
Forum elite
Forum elite
Berichten: 5095
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4413
Contacteer:

Re: Sorrento therapeutics

Bericht door believer »

..
U kunt zich hier registreren waarna u de bijlage kunt bekijken.

believer
Forum elite
Forum elite
Berichten: 5095
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4413
Contacteer:

Re: Sorrento therapeutics

Bericht door believer »

Indrukwekkend,januari 2021,zeker eens door nemen

https://investors.sorrentotherapeutics. ... 6a7a7f3e94
MONEYCAT liked last!

ancaoli
Forum veteraan
Forum veteraan
Berichten: 1877
Lid geworden op: 28 jan 2018 18:54
waarderingen: 994
Contacteer:

Re: Sorrento therapeutics

Bericht door ancaoli »

believer schreef:
11 jan 2021 12:11
Indrukwekkend,januari 2021,zeker eens door nemen

https://investors.sorrentotherapeutics. ... 6a7a7f3e94
T’ziet er inderdaad indrukwekkend uit. Maar is het niet too much?? Ik heb zonet de 22 minuten van Henri beluisterd; het blijft een archi slechte communicator. Je moet echt een Believer zijn om te willen blijven luisteren... Weinig dynamisch, beperkte woordenschat, 0 charisma.
Pipeline is uiteraard enorm maar juist daarom hebben ze misschien niet genoeg focus of we moeten Henri geloven en binnen een paar jaren is Sorrento een van de biotech wereldspelers...
Tot daar de kritische noot. Als ze morgen een FDA en Mexico goedkeuring krijgen krijgt hij al mijn respect. Maar geef ons nu eindelijk eens het te verwachten nieuws; dus geen PR over nog een nieuwe samenwerking. Approvals en centen moeten NU volgen
MONEYCAT liked last!
Vaste Portefeuille:Recticel, WRN, Accentis, Global G, Roularta, Argenx, Agfa, Ontex, OCI, Sorrento, Inventiva

believer
Forum elite
Forum elite
Berichten: 5095
Lid geworden op: 14 jan 2015 17:30
waarderingen: 4413
Contacteer:

Re: Sorrento therapeutics

Bericht door believer »

With such a large portfolio where will they find the necessary funding? This is not an unreasonable question. Here are some sources!
$34 million from DARPA
$78 million in cash
$143 million from 10 million shares x $14.34 Immuno/NK
$460 million from Cellularity IPO in Q2 at $1.7 billion.
58% ownership in Scilex which will also IPO
Potential $1 billion PSS legal settlement
Probable Warpspeed awards for tests and drugs $1 billion+ after EUAs
Revenue streams from tests and drugs after EUAs
Upfront, milestone and royalty income from worldwide marketing partnerships
sepan liked last!

alwaysright
Forum actieveling
Forum actieveling
Berichten: 956
Lid geworden op: 10 mei 2013 19:25
waarderingen: 397
Contacteer:

Re: Sorrento therapeutics

Bericht door alwaysright »

Ik heb er op dit moment geen idee van of Sorrento zich nu richt op een middel tegen Covid-19 of meer bezig zijn met die Covi
Stix maar als je dit hieronder nu weer leest vraag ik me al meer af of alle middelen die nu op de markt zijn,wel doen wat de fabrikant ons wil doen geloven.

Sinovac: Brazil results show Chinese vaccine 50.4% effective

A coronavirus vaccine developed by China's Sinovac has been found to be 50.4% effective in Brazilian clinical trials, according to the latest results released by researchers.

It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval.

The Chinese vaccine is one of two that the Brazilian government has lined up.

Brazil has been one of the countries worst affected by Covid-19.

Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response.

Several countries, including Indonesia, Turkey and Singapore, have placed orders for the vaccine.


Deelnemen aan het forum + meer functies?

Deel kennis en vragen met duizenden beleggers,
minder advertenties, ideaal voor smartphone, betere
gebruikservaring en gratis abonneren op favoriete
onderwerpen. Registreer binnen 1 minuut!



Plaats reactie